Search research articles
Contact Us
Filters
Showing results (91-100 of 137) with videos related to
Page
of 14
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 30, 2004
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis
A Petzold, D Brassat, P Mas, et al.
Human Immunology
|
June 1, 1991
Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls
A Alpérovitch, C Berr, A Cambon-Thomsen, et al.
Clinical Neuropharmacology
|
October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis
C Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1983
[Familial Alzheimer's disease: a study of HLA markers]
N Delasnerie-Lauprêtre, M Calot, E Ohayon, et al.
European Neurology
|
January 1, 1991
Observer disagreement in rating neurologic impairment in multiple sclerosis: facts and consequences
M H Verdier-Taillefer, M Zuber, O Lyon-Caen, et al.
Therapie
|
February 24, 2001
[Midodrine (Gutron) prescription practice at a University Hospital Center]
K Desboeuf, J M Senard, A Pavy-Le-Traon, et al.
Genes and Immunity
|
February 24, 2001
No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients
H Coppin, M T Ribouchon, P Bausero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 11, 2003
Towards a european network for multiple sclerosis trials (ENMST)
L Kappos, C Polman, A J Thompson, et al.
Immunogenetics
|
January 1, 1994
TCRB-V gene usage in monozygotic twins discordant for multiple sclerosis
M P Roth, J Riond, E Champagne, et al.
Science (New York, N.Y.)
|
May 2, 1997
Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS
J Yaouanq, G Semana, S Eichenbaum, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 137) with videos related to
Sort By:
Page
of 14
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 30, 2004
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis
A Petzold, D Brassat, P Mas, et al.
Human Immunology
|
June 1, 1991
Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls
A Alpérovitch, C Berr, A Cambon-Thomsen, et al.
Clinical Neuropharmacology
|
October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis
C Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1983
[Familial Alzheimer's disease: a study of HLA markers]
N Delasnerie-Lauprêtre, M Calot, E Ohayon, et al.
European Neurology
|
January 1, 1991
Observer disagreement in rating neurologic impairment in multiple sclerosis: facts and consequences
M H Verdier-Taillefer, M Zuber, O Lyon-Caen, et al.
Therapie
|
February 24, 2001
[Midodrine (Gutron) prescription practice at a University Hospital Center]
K Desboeuf, J M Senard, A Pavy-Le-Traon, et al.
Genes and Immunity
|
February 24, 2001
No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients
H Coppin, M T Ribouchon, P Bausero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 11, 2003
Towards a european network for multiple sclerosis trials (ENMST)
L Kappos, C Polman, A J Thompson, et al.
Immunogenetics
|
January 1, 1994
TCRB-V gene usage in monozygotic twins discordant for multiple sclerosis
M P Roth, J Riond, E Champagne, et al.
Science (New York, N.Y.)
|
May 2, 1997
Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS
J Yaouanq, G Semana, S Eichenbaum, et al.
Page
of 14